Cargando…
Effect of the Pandemic Outbreak on ICU-Associated Infections and Antibiotic Prescription Trends in Non-COVID19 Acute Respiratory Failure Patients
Background: The COVID-19 pandemic had a relevant impact on the organization of intensive care units (ICU) and may have reduced the overall compliance with healthcare-associated infections (HAIs) prevention programs. Invasively ventilated patients are at high risk of ICU-associated infection, but the...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739506/ https://www.ncbi.nlm.nih.gov/pubmed/36498656 http://dx.doi.org/10.3390/jcm11237080 |
_version_ | 1784847823473213440 |
---|---|
author | Bussolati, Enrico Cultrera, Rosario Quaranta, Alessandra Cricca, Valentina Marangoni, Elisabetta La Rosa, Riccardo Bertacchini, Sara Bellonzi, Alessandra Ragazzi, Riccardo Volta, Carlo Alberto Spadaro, Savino Scaramuzzo, Gaetano |
author_facet | Bussolati, Enrico Cultrera, Rosario Quaranta, Alessandra Cricca, Valentina Marangoni, Elisabetta La Rosa, Riccardo Bertacchini, Sara Bellonzi, Alessandra Ragazzi, Riccardo Volta, Carlo Alberto Spadaro, Savino Scaramuzzo, Gaetano |
author_sort | Bussolati, Enrico |
collection | PubMed |
description | Background: The COVID-19 pandemic had a relevant impact on the organization of intensive care units (ICU) and may have reduced the overall compliance with healthcare-associated infections (HAIs) prevention programs. Invasively ventilated patients are at high risk of ICU-associated infection, but there is little evidence regarding the impact of the pandemic on their occurrence in non-COVID-19 patients. Moreover, little is known of antibiotic prescription trends in the ICU during the first wave of the pandemic. The purpose of this investigation is to assess the incidence, characteristics, and risk factors for ICU-associated HAIs in a population of invasively ventilated patients affected by non-COVID-19 acute respiratory failure (ARF) admitted to the ICU in the first wave of the COVID-19 pandemic, and to evaluate the ICU antimicrobial prescription strategies. Moreover, we compared HAIs and antibiotic use to a cohort of ARF patients admitted to the ICU the year before the pandemic during the same period. Methods: this is a retrospective, single-centered cohort study conducted at S. Anna University Hospital (Ferrara, Italy). We enrolled patients admitted to the ICU for acute respiratory failure requiring invasive mechanical ventilation (MV) between February and April 2020 (intra-pandemic group, IP) and February and April 2019 (before the pandemic group, PP). We excluded patients admitted to the ICU for COVID-19 pneumonia. We recorded patients’ baseline characteristics, ICU-associated procedures and devices. Moreover, we evaluated antimicrobial therapy and classified it as prophylactic, empirical or target therapy, according to the evidence of infection at the time of prescription and to the presence of a positive culture sample. We compared the results of the two groups (PP and IP) to assess differences between the two years. Results: One hundred and twenty-eight patients were screened for inclusion and 83 patients were analyzed, 45 and 38 in the PP and I group, respectively. We found a comparable incidence of HAIs (62.2% vs. 65.8%, p = 0.74) and multidrug-resistant (MDR) isolations (44.4% vs. 36.8% p= 0.48) in the two groups. The year of ICU admission was not independently associated with an increased risk of developing HAIs (OR = 0.35, 95% CI 0.16–1.92, p = 0.55). The approach to antimicrobial therapy was characterized by a significant reduction in total antimicrobial use (21.4 ± 18.7 vs. 11.6 ± 9.4 days, p = 0.003), especially of target therapy, in the IP group. Conclusions: ICU admission for non-COVID-19 ARF during the first wave of the SARS-CoV-2 pandemic was not associated with an increased risk of ICU-associated HAIs. Nevertheless, ICU prescription of antimicrobial therapy changed and significantly decreased during the pandemic. |
format | Online Article Text |
id | pubmed-9739506 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97395062022-12-11 Effect of the Pandemic Outbreak on ICU-Associated Infections and Antibiotic Prescription Trends in Non-COVID19 Acute Respiratory Failure Patients Bussolati, Enrico Cultrera, Rosario Quaranta, Alessandra Cricca, Valentina Marangoni, Elisabetta La Rosa, Riccardo Bertacchini, Sara Bellonzi, Alessandra Ragazzi, Riccardo Volta, Carlo Alberto Spadaro, Savino Scaramuzzo, Gaetano J Clin Med Article Background: The COVID-19 pandemic had a relevant impact on the organization of intensive care units (ICU) and may have reduced the overall compliance with healthcare-associated infections (HAIs) prevention programs. Invasively ventilated patients are at high risk of ICU-associated infection, but there is little evidence regarding the impact of the pandemic on their occurrence in non-COVID-19 patients. Moreover, little is known of antibiotic prescription trends in the ICU during the first wave of the pandemic. The purpose of this investigation is to assess the incidence, characteristics, and risk factors for ICU-associated HAIs in a population of invasively ventilated patients affected by non-COVID-19 acute respiratory failure (ARF) admitted to the ICU in the first wave of the COVID-19 pandemic, and to evaluate the ICU antimicrobial prescription strategies. Moreover, we compared HAIs and antibiotic use to a cohort of ARF patients admitted to the ICU the year before the pandemic during the same period. Methods: this is a retrospective, single-centered cohort study conducted at S. Anna University Hospital (Ferrara, Italy). We enrolled patients admitted to the ICU for acute respiratory failure requiring invasive mechanical ventilation (MV) between February and April 2020 (intra-pandemic group, IP) and February and April 2019 (before the pandemic group, PP). We excluded patients admitted to the ICU for COVID-19 pneumonia. We recorded patients’ baseline characteristics, ICU-associated procedures and devices. Moreover, we evaluated antimicrobial therapy and classified it as prophylactic, empirical or target therapy, according to the evidence of infection at the time of prescription and to the presence of a positive culture sample. We compared the results of the two groups (PP and IP) to assess differences between the two years. Results: One hundred and twenty-eight patients were screened for inclusion and 83 patients were analyzed, 45 and 38 in the PP and I group, respectively. We found a comparable incidence of HAIs (62.2% vs. 65.8%, p = 0.74) and multidrug-resistant (MDR) isolations (44.4% vs. 36.8% p= 0.48) in the two groups. The year of ICU admission was not independently associated with an increased risk of developing HAIs (OR = 0.35, 95% CI 0.16–1.92, p = 0.55). The approach to antimicrobial therapy was characterized by a significant reduction in total antimicrobial use (21.4 ± 18.7 vs. 11.6 ± 9.4 days, p = 0.003), especially of target therapy, in the IP group. Conclusions: ICU admission for non-COVID-19 ARF during the first wave of the SARS-CoV-2 pandemic was not associated with an increased risk of ICU-associated HAIs. Nevertheless, ICU prescription of antimicrobial therapy changed and significantly decreased during the pandemic. MDPI 2022-11-29 /pmc/articles/PMC9739506/ /pubmed/36498656 http://dx.doi.org/10.3390/jcm11237080 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bussolati, Enrico Cultrera, Rosario Quaranta, Alessandra Cricca, Valentina Marangoni, Elisabetta La Rosa, Riccardo Bertacchini, Sara Bellonzi, Alessandra Ragazzi, Riccardo Volta, Carlo Alberto Spadaro, Savino Scaramuzzo, Gaetano Effect of the Pandemic Outbreak on ICU-Associated Infections and Antibiotic Prescription Trends in Non-COVID19 Acute Respiratory Failure Patients |
title | Effect of the Pandemic Outbreak on ICU-Associated Infections and Antibiotic Prescription Trends in Non-COVID19 Acute Respiratory Failure Patients |
title_full | Effect of the Pandemic Outbreak on ICU-Associated Infections and Antibiotic Prescription Trends in Non-COVID19 Acute Respiratory Failure Patients |
title_fullStr | Effect of the Pandemic Outbreak on ICU-Associated Infections and Antibiotic Prescription Trends in Non-COVID19 Acute Respiratory Failure Patients |
title_full_unstemmed | Effect of the Pandemic Outbreak on ICU-Associated Infections and Antibiotic Prescription Trends in Non-COVID19 Acute Respiratory Failure Patients |
title_short | Effect of the Pandemic Outbreak on ICU-Associated Infections and Antibiotic Prescription Trends in Non-COVID19 Acute Respiratory Failure Patients |
title_sort | effect of the pandemic outbreak on icu-associated infections and antibiotic prescription trends in non-covid19 acute respiratory failure patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739506/ https://www.ncbi.nlm.nih.gov/pubmed/36498656 http://dx.doi.org/10.3390/jcm11237080 |
work_keys_str_mv | AT bussolatienrico effectofthepandemicoutbreakonicuassociatedinfectionsandantibioticprescriptiontrendsinnoncovid19acuterespiratoryfailurepatients AT cultrerarosario effectofthepandemicoutbreakonicuassociatedinfectionsandantibioticprescriptiontrendsinnoncovid19acuterespiratoryfailurepatients AT quarantaalessandra effectofthepandemicoutbreakonicuassociatedinfectionsandantibioticprescriptiontrendsinnoncovid19acuterespiratoryfailurepatients AT criccavalentina effectofthepandemicoutbreakonicuassociatedinfectionsandantibioticprescriptiontrendsinnoncovid19acuterespiratoryfailurepatients AT marangonielisabetta effectofthepandemicoutbreakonicuassociatedinfectionsandantibioticprescriptiontrendsinnoncovid19acuterespiratoryfailurepatients AT larosariccardo effectofthepandemicoutbreakonicuassociatedinfectionsandantibioticprescriptiontrendsinnoncovid19acuterespiratoryfailurepatients AT bertacchinisara effectofthepandemicoutbreakonicuassociatedinfectionsandantibioticprescriptiontrendsinnoncovid19acuterespiratoryfailurepatients AT bellonzialessandra effectofthepandemicoutbreakonicuassociatedinfectionsandantibioticprescriptiontrendsinnoncovid19acuterespiratoryfailurepatients AT ragazziriccardo effectofthepandemicoutbreakonicuassociatedinfectionsandantibioticprescriptiontrendsinnoncovid19acuterespiratoryfailurepatients AT voltacarloalberto effectofthepandemicoutbreakonicuassociatedinfectionsandantibioticprescriptiontrendsinnoncovid19acuterespiratoryfailurepatients AT spadarosavino effectofthepandemicoutbreakonicuassociatedinfectionsandantibioticprescriptiontrendsinnoncovid19acuterespiratoryfailurepatients AT scaramuzzogaetano effectofthepandemicoutbreakonicuassociatedinfectionsandantibioticprescriptiontrendsinnoncovid19acuterespiratoryfailurepatients |